- Home
- COEP vs LONA Comparison
COEP vs LONA Comparison
Compare COEP & LONA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | COEP | LONA |
|---|---|---|
| Founded | 2017 | 2011 |
| Country | United States | United States |
| Employees | 6 | 26 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 91.2M | 83.7M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | COEP | LONA |
|---|---|---|
| Price | $16.52 | $8.32 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $10.00 |
| AVG Volume (30 Days) | ★ 47.1K | 33.8K |
| Earning Date | 05-13-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $6.80 | $4.21 |
| 52 Week High | $21.41 | $14.21 |
Technical Indicators
Market Signals| Indicator | COEP | LONA |
|---|---|---|
| Relative Strength Index (RSI) | 72.18 | 46.73 |
| Support Level | $13.77 | $8.00 |
| Resistance Level | $19.19 | $12.47 |
| Average True Range (ATR) | 1.15 | 1.09 |
| MACD | 0.47 | -0.25 |
| Stochastic Oscillator | 87.62 | 20.12 |
Price Performance
Historical ComparisonAbout COEP Coeptis Therapeutics Holdings Inc.
Coeptis Therapeutics Holdings Inc is a biopharmaceutical and technology company. The biopharmaceutical division focuses on developing cell therapy platforms for cancer, autoimmune, and infectious diseases. Coeptis aims to advance treatment paradigms and improve patient outcomes through its research and development efforts. The technology division focuses on enhancing operational capabilities through technologies. This division features AI-powered marketing software and robotic process automation tools designed to optimize business processes and improve overall efficiency. It derives the majority of the revenue from the Technology segment.
About LONA LeonaBio Inc. Common Stock
LeonaBio Inc is a clinical-stage biopharmaceutical company dedicated to the development of novel therapeutics for high unmet medical needs, including treatment-resistant metastatic breast cancer and amyotrophic lateral sclerosis (ALS).